How many insider declarations has Summit Investors GE IX/VC IV (UK), L.P. filed?

Summit Investors GE IX/VC IV (UK), L.P. has filed 2 public insider declarations with SEC (Form 4).

What is Summit Investors GE IX/VC IV (UK), L.P.'s role?

Summit Investors GE IX/VC IV (UK), L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Summit Investors GE IX/VC IV (UK), L.P. report trades for?

Summit Investors GE IX/VC IV (UK), L.P. reports trades for 2 companies, including LifeStance Health Group, Inc..

← Executives ★ Sign in to follow

SI

Summit Investors GE IX/VC IV (UK), L.P.

·SEC (Form 4)

LifeStance Health Group, Inc.KLAVIYO, INC

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by Summit Investors GE IX/VC IV (UK), L.P.. Officer active across 2 companies, notably LifeStance Health Group, Inc.. Cumulatively, 2 filings have been recorded. History available since 10 August 2026. The latest transaction was filed on 11 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Summit Investors GE IX/VC IV (UK), L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

LifeStance Health Group, Inc. (US)KLAVIYO, INC (US)

申报2 总计

●

Summit Investors GE IX/VC IV (UK), L.P.

10% Stockholder高管2026年8月11日KLAVIYO, INC

US$37,0140来源 ↗

2,016 股@ US$18.36Series A Common stock, par value $0.001 per shareSEC144:0001846709-26-000005

●

Summit Investors GE IX/VC IV (UK), L.P.

Owner高管2026年8月10日LifeStance Health Group, Inc.

US$13,51915来源 ↗

1,273 股@ US$10.620.0003% mcap100.0% 占其流量Common StockSEC144:0001846709-26-000003

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SI

Summit Investors GE IX/VC IV (UK), L.P.

·SEC (Form 4)

LifeStance Health Group, Inc.KLAVIYO, INC

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by Summit Investors GE IX/VC IV (UK), L.P.. Officer active across 2 companies, notably LifeStance Health Group, Inc.. Cumulatively, 2 filings have been recorded. History available since 10 August 2026. The latest transaction was filed on 11 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.